On August 15, Tevogen Bio entered into a definitive agreement for a $6 million Series C Preferred Stock investment (“Series C”). The shares of the Series C have a 7.5% annual dividend and are ...

While Ideaya is letting Amgen go, it is retaining an interest in MAT2A-PRMT5 combinations. Ideaya has a PRMT5 inhibitor, ...

Amgen, Inc. ( NASDAQ: AMGN) Oppenheimer 35th Annual Healthcare Life Sciences Conference Call February 12, 2025 11:20 AM ET Narimon Honarpour - Senior Vice President, Global Development Justin Claeys - ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

As a result, Healthpeak’s life science and medical office portfolios are now prominently featured in the company's portfolio as the proceeds from the senior housing sales were reinvested into these ...

Biotech stocks are revolutionizing healthcare with breakthrough innovations, leading the charge in precision therapies and ...

It’s Black History Month! Gayle Anderson reports from the California Science Center about the development of the new Samuel ...

This screenshot shows the browser running on a NeXT computer in 1993. Only a few users had access to a NeXT computer platform on which the first browser ran, but development soon started on a simpler, ...

The adjusted risk for COPD was elevated among adults who identified as regular cigarette smokers before age 15 years, ...

Biosimilar Pipeline Analysis Market BURLINGAME, CA, UNITED STATES, February 6, 2025 /EINPresswire / -- The global Biosimilar Pip ...

Elsewhere, cell therapy developer Turnstone Biologics announced a second round of layoffs and plans to explore “strategic alternatives.” ...

Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks ...